160
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Higher Levels of Plasma TNF-α and Neuropeptide Y in Hypertensive Patients with Obstructive Sleep Apnea Syndrome

, , , , , , & show all
Pages 54-60 | Received 12 Sep 2008, Accepted 29 Oct 2008, Published online: 10 Feb 2010

REFERENCES

  • Paul EP, Terry Y, Mari P, James S. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378–1384.
  • Punginathn D. Obstructive sleep apnea and cardiovascular risk. Ther Clin R Manag 2007;3:1105–1111.
  • Horner RL, Innes JA, Morrell MJ, Shea SA, Guz A. The effect of sleep on reflex genioglossus muscle activation by stimuli of negative airway pressure in humans. J Physiol 1994;476:141–151.
  • Susheel PP, Hartmut S, Jason JM, Elizabeth G, Alan RS, Philip LS. Neuromechanical control of upper airway patency during sleep. J Appl Physiol 2007;102:547–556.
  • Robert BF, John T, David PW, Atul M, Jill R, Karen S, Darci K, Robert JP. The effect of sleep onset on upper airway muscle activity in patients with sleep apnoea versus controls. J Physiol 2005;564:549–562.
  • Zhang RM, Gao M, Zhang Zh, Wang SF, Jiang L, Wang HQ, Zhu B. Alteration of plasma neuropeptide Y in patients with essential hypertension. Chin J Hypertension 2007;15: 731–734.
  • Stanley BG. Neuropeptide Y in multiple hypothalamic sites control eating behavior, endocrine and autonomic systems for energy balance. In: Colmers WF, Wahlestedt C, eds. The biology of neuropeptide Y and related peptides. Totowa, NJ: Humana Press 1993:457–509.
  • Sakurai S, Nishijima T, Takahashi S, Yamauchi K, Arihara Z, Takahashi K. Low plasma Orexin-A levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome. Chest 2005;127:731–737.
  • Nishijima T, Sakurai S, Arihara Z, Takahashi K. Plasma orexin-A-like immunoreactivity in patients with sleep apnea hypopnea syndrome. Peptides 2003;24:407–411.
  • Haipog U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: A working hypothesis. Respiration 2003;70:665–671.
  • Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, Yamamoto M, Adachi Mitsuru. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004;126:1473–1479.
  • Entzian P, Linnemann K, Schlaak M, . Obstructive sleep apnea and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996;153:1080–1086.
  • Stierer T, Punjabi NM. Demographics and diagnosis of obstructive sleep apnea. Anesthesiol Clin North Am 2005; 23:405–420.
  • Cooperative Meta-Analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chinese J Epidemiol 2002;23:5–10.
  • American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research: The report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667–689.
  • Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgensterm BZ. Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460–2470.
  • Sesso HD, Julie EB, Nader R, Gavin JB, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003;290:2945–2951.
  • Srinivas S, Masudul H, Dewan SA, Majid, Joseph F. Involvement of tumor necrosis factor-α in angiotensin II–mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 2008;51:1345–1351.
  • Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196–4200.
  • Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112: 1796–1808.
  • Xu H, Uysal KT, Becherer JD, Arner P, Hotamisligil GS. Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Diabetes 2002;51:1876–1883.
  • Matsumura K, Tsuchihashi T, Abe I. Central cardiovascular action of neuropeptide Y in conscious rabbits. Hypertension 2000;36:1040–1044.
  • Thulin T, Erlinge D. Neuropeptide Y and hypertension. Nutrition 1995;11:495–497.
  • Antonia B, Ferran B, Elena L, Mo´nica de la P, Joaquin DC, Antoni L, Margalida B, Lourdes G, Alvar GNA. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2005;171: 183–187.
  • Gamse R, Posch M, Saria A, Jancso G. Several mediators appear to interact in neurogenic inflammation. Acta Physiol Hung 1987; 69:343–354.
  • Foreman JC. Peptides and neurogenic inflammation. Br Med Bull 1987;43:386–400.
  • Maggi CA. The effects of tachykinins on inflammatory and immune cells. Regul Pept 1997;70:75–90.
  • Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1218–1221.
  • Djida AA, Valerie T, Luca G, Laurent Y, Matthieu J, David A, Lee EE, Hubert V, Youssef A. The proinflammatory cytokines tumor necrosis factor-α and interleukin-1 stimulate neuropeptide gene transcription and secretion in adrenochromaffin cells via activation of extracellularly regulated kinase 1/2 and p38 protein kinases, and activator protein-1 transcription factors. Mol Endocrinol 2004;18:1721–1739.
  • Ryan CF, Love LL. Mechanical properties of the velopharynx in obese patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996;154:806–812.
  • Mortimore IL, Marshall I, Wraith PK, Sellar RJ, Douglas NJ. Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med 1998;157: 280–283.
  • Philip AK, Subramanian R, Chunling L, Linda W, Gouri R. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:745–751.
  • Antonio LC, Carlo A, Giuseppe M. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 2004;82:4–11.
  • Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993;103: 1763–1768.
  • Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897–1904.
  • Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334: 374–381.
  • Macdonald IA. Advances in our understanding of the role of the sympathetic nervous system in obesity. Int J Obes Relat Metab Disord 1995;19 (suppl):S2–S7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.